METHOD AND SYSTEM FOR ADMINISTRATION OF PULMONARY SURFACTANT BY ATOMISATION Russian patent published in 2018 - IPC A61M11/00 

Abstract RU 2671205 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medical equipment. System for delivering a medicament, comprising a pulmonary surfactant to patients that are spontaneously breathing preterm neonates, comprises a catheter adapted to reach the retro-pharyngeal region of the patient and having least a first channel adapted to convey in the patient's pharyngeal region a flow of liquid medicament and at least a second channel adapted to convey in the patient's pharyngeal region a pressurised flow of gas. First pump means is connected to a first end of the first channel and is adapted to create a pressure which pushes the column of liquid medicament towards the second end of the at least first channel. Second pump means is connected to a first end of the second channel and is adapted to create the flow of pressurised gas, so that when the column of liquid medicament and the pressurised gas meet in the pharyngeal cavity, the liquid column is broken into a plurality of fine particles causing the atomised medicament to be delivered into the patient's lungs. Pressure detector is spatially separate from the first and second channel and serves for measuring values indicative of the pressure in the patient pharyngeal cavity, such values being used to determine whether the patient is in an inspiration or in an expiration phase. Pressure detector comprises a third channel adapted to convey to the patients pharyngeal region a flow of an aqueous solution; a third pump means connected to a first end of the third channel and adapted to create the flow of aqueous solution; and a pressure sensor connected to the third channel for measuring a value indicative of the pressure on the flow of the aqueous solution. First pump means is adapted for selective activation only in the inspiratory phase. Kit for delivering a medicament into a patient's retro-pharyngeal space by atomisation is disclosed.

EFFECT: technical result consists in providing automatic synchronisation of delivery of a medicament with respiratory rhythm.

13 cl, 8 dwg, 2 tbl

Similar patents RU2671205C2

Title Year Author Number
DEVICE FOR DRUG DELIVERY INTO LUNG BY MEANS OF CATHETER 2016
  • Dellaka', Raffaele
  • Milezi, Ilaria
  • Tsannin, Emanuela
RU2714183C2
THERAPEUTIC COMBINATION FOR THE TREATMENT OF DEVELOPING BPD CONTAINING PULMONARY SURFACTANT AND STEROID 2017
  • Fabbri, Laura
  • Salomone, Fabrizio
RU2757902C2
THERAPEUTIC COMBINATION CONTAINING PULMONARY SURFACTANT AND STEROID FOR PREVENTION OF BPD 2019
  • Jobe, Alan
  • Schmidt, Augusto Santos
  • Hillman, Noah
  • Kemp, Matthew
RU2823855C2
THERAPEUTIC COMBINATION CONTAINING LUNG SURFACTANT AND ANTIOXIDANT ENZYMES 2010
  • Dani Karlo
RU2538675C2
THERAPEUTIC COMBINATION CONTAINING LUNG SURFACTANT AND STEROID 2010
  • Giossi Massimo
  • Razzetti Roberta
  • Chiesi Paolo
RU2533450C2
METHOD OF PREVENTING BRONCHOPULMONARY DYSPLASIA IN NEWBORN BABIES WITH VERY LOW AND EXTREMELY LOW BODY WEIGHT AT BIRTH 2009
  • Ryndin Andrej Jur'Evich
  • Antonov Al'Bert Grigor'Evich
RU2416388C1
METHOD FOR PREDICTION OF BRONCHOPULMONARY DYSPLASIA IN NEWBORNS WITH VERY LOW OR EXTREMELY LOW BIRTH BODY WEIGHT 2012
  • Vinogradova Irina Valer'Evna
  • Belova Anastasija Nikolaevna
  • Vinogradov Dmitrij Andreevich
  • Volchkov Vladimir Andreevich
  • Sejliev Andrej Alievich
  • Rozenberg Oleg Aleksandrovich
RU2504395C1
BREATHING SYSTEM ADAPTER AND PROXIMAL AEROSOL DELIVERY SYSTEM 2009
  • Mejzela Jan
  • Khenderson Kristofer
RU2463084C2
RECONSTITUTED PULMONARY SURFACTANTS 2013
  • Jokhansson Yan
  • Kurstedt Ture
RU2656185C2
PULMONARY SURFACTANT COMPOSITIONS AND METHODS OF USING THEM PROMOTING MUCUS ELIMINATION 2007
  • Dzhonson Mark I.
  • Sigal Robert
  • Khofmann Tomas
  • Kejpitola Robert Dzh.
RU2455021C2

RU 2 671 205 C2

Authors

Dellaka' Raffaele

Milezi Ilaria

Di Checho Mario

Syuell Rodzher Fejn

Tejlor Donal Dzhozef

Dates

2018-10-30Published

2014-10-16Filed